Biotechnology
The Biotechnology industry has a total of 595 stocks, with a combined market cap of $1.25 trillion and total revenue of $123.28 billion.
Market Cap
1.25T
Revenue
123.28B
Profits
-34.11B
PE Ratio
n/a
Profit Margin
-27.67%
Dividend Yield
0.04%
595 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 132.01B | -2.94% | 1,177,136 | 12.95B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 92.66B | -2.35% | 718,056 | 16.90B |
| 3 | MRNA | Moderna, Inc. | 80.65B | 1.29% | 8,204,149 | 2.53B |
| 4 | ARGX | argenx SE | 58.91B | 0.08% | 288,633 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 45.66B | -0.97% | 246,122 | 6.45B |
| 6 | RPRX | Royalty Pharma plc | 38.84B | -1.38% | 3,250,012 | 2.62B |
| 7 | RVMD | Revolution Medicines, Inc. | 34.48B | -0.24% | 3,353,928 | 197.56M |
| 8 | GMAB | Genmab A/S | 32.50B | 0.75% | 4,350,664 | 4.30B |
| 9 | INSM | Insmed Incorporated | 31.69B | 20.58% | 14,410,443 | 1.52B |
| 10 | ROIV | Roivant Sciences Ltd. | 28.23B | 0.59% | 4,934,810 | 41.08M |
| 11 | INCY | Incyte Corporation | 23.62B | -1.64% | 1,177,317 | 6.01B |
| 12 | BNTX | BioNTech SE | 20.18B | -2.26% | 1,497,508 | 2.75B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 19.80B | -1.06% | 2,153,897 | 5.01B |
| 14 | ASND | Ascendis Pharma A/S | 16.79B | -5.32% | 970,397 | 1.37B |
| 15 | EXEL | Exelixis, Inc. | 16.06B | -3.60% | 2,741,455 | 2.50B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.23B | 0.22% | 2,174,126 | 945.54M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 15.18B | -4.57% | 1,437,266 | 4.72B |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.90B | -0.02% | 5,200,734 | 3.66B |
| 19 | TECH | Bio-Techne Corporation | 11.42B | -0.07% | 3,322,608 | 1.23B |
| 20 | HALO | Halozyme Therapeutics, Inc. | 10.61B | -2.88% | 3,910,599 | 1.80B |
| 21 | KYMR | Kymera Therapeutics, Inc. | 10.19B | -1.44% | 723,173 | 102.24M |
| 22 | KRYS | Krystal Biotech, Inc. | 9.36B | 0.15% | 295,865 | 470.03M |
| 23 | SYRE | Spyre Therapeutics, Inc. | 9.27B | -3.77% | 628,946 | - |
| 24 | PCVX | Vaxcyte, Inc. | 9.24B | -0.27% | 982,102 | - |
| 25 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.22B | -0.34% | 416,637 | 1.43B |
| 26 | TGTX | TG Therapeutics, Inc. | 9.09B | -1.88% | 1,658,393 | 897.76M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 8.69B | 1.87% | 634,645 | 7.46M |
| 28 | SMMT | Summit Therapeutics Inc. | 8.45B | 0.67% | 9,027,991 | - |
| 29 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.10B | -1.88% | 1,112,680 | 280.75M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 8.09B | -2.47% | 554,086 | 551.69M |
| 31 | TWST | Twist Bioscience Corporation | 7.61B | -4.07% | 2,254,597 | 459.43M |
| 32 | CGON | CG Oncology, Inc. | 7.32B | 2.38% | 2,519,944 | 6.17M |
| 33 | ABVX | ABIVAX Société Anonyme | 7.28B | -3.79% | 2,327,830 | 5.33M |
| 34 | CYTK | Cytokinetics, Incorporated | 7.17B | 0.27% | 1,744,346 | 113.29M |
| 35 | AXSM | Axsome Therapeutics, Inc. | 7.14B | 1.25% | 639,646 | 865.27M |
| 36 | CORT | Corcept Therapeutics Incorporated | 7.11B | -4.15% | 950,358 | 963.65M |
| 37 | IBRX | ImmunityBio, Inc. | 6.99B | -1.94% | 11,131,353 | 182.57M |
| 38 | IMVT | Immunovant, Inc. | 6.73B | -1.96% | 731,036 | - |
| 39 | ORKA | Oruka Therapeutics, Inc. | 6.62B | 1.91% | 927,132 | - |
| 40 | KOD | Kodiak Sciences Inc. | 6.39B | 0.09% | 521,856 | - |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 6.24B | 3.27% | 777,361 | 670.78M |
| 42 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.17B | 1.25% | 2,559,217 | 450.82M |
| 43 | SRRK | Scholar Rock Holding Corporation | 6.15B | 4.94% | 2,453,749 | 570.00K |
| 44 | BLTE | Belite Bio, Inc | 6.13B | -3.33% | 138,885 | - |
| 45 | LGND | Ligand Pharmaceuticals Incorporated | 5.74B | -3.94% | 168,865 | 253.83M |
| 46 | CAI | Caris Life Sciences, Inc. | 5.32B | -4.92% | 3,633,723 | 1.05B |
| 47 | MANE | Veradermics, Incorporated | 5.25B | -0.38% | 293,542 | - |
| 48 | ERAS | Erasca, Inc. | 4.99B | 3.34% | 4,784,373 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 4.87B | -3.16% | 801,950 | 1.16B |
| 50 | COGT | Cogent Biosciences, Inc. | 4.83B | -0.25% | 1,652,532 | - |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 4.78B | 1.01% | 896,825 | 2.72M |
| 52 | TVTX | Travere Therapeutics, Inc. | 4.64B | -3.86% | 1,792,704 | 651.03M |
| 53 | IONS | Ionis Pharmaceuticals, Inc. | 4.53B | -0.62% | 3,063,403 | 960.09M |
| 54 | EWTX | Edgewise Therapeutics, Inc. | 4.51B | -0.48% | 1,193,954 | - |
| 55 | DFTX | Definium Therapeutics, Inc. | 4.04B | 1.24% | 3,074,004 | - |
| 56 | TNGX | Tango Therapeutics, Inc. | 3.85B | 3.75% | 1,807,264 | 53.81M |
| 57 | TARS | Tarsus Pharmaceuticals, Inc. | 3.83B | 2.26% | 615,401 | 682.20M |
| 58 | CRSP | CRISPR Therapeutics AG | 3.78B | -3.14% | 4,099,643 | 25.17M |
| 59 | XENE | Xenon Pharmaceuticals Inc. | 3.69B | -0.50% | 1,281,705 | 7.50M |
| 60 | VRDN | Viridian Therapeutics, Inc. | 3.57B | 4.38% | 4,018,084 | 26.31M |
| 61 | RLAY | Relay Therapeutics, Inc. | 3.52B | -3.63% | 1,884,244 | 10.35M |
| 62 | IRON | Disc Medicine, Inc. | 3.47B | -2.40% | 646,409 | - |
| 63 | PBLS | Parabilis Medicines, Inc. | 3.46B | -2.97% | 805,678 | 2.26M |
| 64 | ARQT | Arcutis Biotherapeutics, Inc. | 3.44B | -1.59% | 1,330,789 | 508.68M |
| 65 | ABCL | AbCellera Biologics Inc. | 3.42B | -4.99% | 2,501,247 | 67.85M |
| 66 | ELVN | Enliven Therapeutics, Inc. | 3.42B | 3.39% | 993,370 | - |
| 67 | IOVA | Iovance Biotherapeutics, Inc. | 3.38B | -2.27% | 8,574,753 | 378.98M |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.30B | -1.26% | 2,769,801 | - |
| 69 | LEGN | Legend Biotech Corporation | 3.12B | -0.92% | 2,367,889 | 1.36B |
| 70 | ACAD | Acadia Pharmaceuticals Inc. | 3.04B | -1.35% | 1,450,789 | 1.20B |
| 71 | SLS | SELLAS Life Sciences Group, Inc. | 3.03B | -17.21% | 36,264,142 | - |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.00B | 1.01% | 2,437,391 | - |
| 73 | TLX | Telix Pharmaceuticals Limited | 3.00B | -2.79% | 221,529 | 890.79M |
| 74 | VCEL | Vericel Corporation | 2.97B | -0.66% | 688,761 | 324.17M |
| 75 | ADMA | ADMA Biologics, Inc. | 2.96B | -1.62% | 3,623,935 | 519.15M |
| 76 | DNLI | Denali Therapeutics Inc. | 2.92B | -1.09% | 1,266,988 | 21.38M |
| 77 | CELC | Celcuity Inc. | 2.77B | 1.28% | 1,463,338 | - |
| 78 | MBX | MBX Biosciences, Inc. | 2.65B | -0.02% | 748,194 | - |
| 79 | XNCR | Xencor, Inc. | 2.55B | -1.10% | 1,091,456 | 200.49M |
| 80 | IDYA | IDEAYA Biosciences, Inc. | 2.53B | -1.21% | 1,420,975 | 36.54M |
| 81 | ZLAB | Zai Lab Limited | 2.46B | -0.86% | 611,424 | 441.73M |
| 82 | NAMS | NewAmsterdam Pharma Company N.V. | 2.34B | -1.17% | 1,983,902 | 25.94M |
| 83 | RCUS | Arcus Biosciences, Inc. | 2.27B | 0.13% | 1,074,686 | 100.00M |
| 84 | PHVS | Pharvaris N.V. | 2.24B | 0.35% | 286,129 | - |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.20B | 1.49% | 751,759 | 158.00K |
| 86 | LKFT | Lakefront Biotherapeutics NV | 2.17B | -2.00% | 293,297 | 1.13B |
| 87 | PVLA | Palvella Therapeutics, Inc. | 2.13B | -0.55% | 150,425 | - |
| 88 | BEAM | Beam Therapeutics Inc. | 2.09B | -0.33% | 4,214,272 | 146.64M |
| 89 | BHVN | Biohaven Ltd. | 2.06B | 5.81% | 3,262,549 | - |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | -1.59% | 968,578 | 321.74M |
| 91 | IMNM | Immunome, Inc. | 1.96B | -1.01% | 881,284 | 4.02M |
| 92 | TRVI | Trevi Therapeutics, Inc. | 1.96B | 1.55% | 2,284,870 | - |
| 93 | FTRE | Fortrea Holdings Inc. | 1.94B | -1.71% | 1,498,410 | 2.67B |
| 94 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | -0.39% | 804,704 | 989.36M |
| 95 | VERA | Vera Therapeutics, Inc. | 1.93B | 4.57% | 1,050,415 | 10.28M |
| 96 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.87B | -2.57% | 2,615,469 | 213.00M |
| 97 | TRAX | First Tracks Biotherapeutics, Inc. | 1.87B | -0.09% | 433,353 | - |
| 98 | SEPN | Septerna, Inc. | 1.86B | -0.63% | 209,024 | 96.27M |
| 99 | COAG | Hemab Therapeutics Holdings, Inc. | 1.86B | 1.81% | 248,303 | - |
| 100 | ZYME | Zymeworks Inc. | 1.85B | 3.15% | 1,011,381 | 265.97M |
| 101 | LYCA | Lycia Therapeutics, Inc. | 1.83B | 1.34% | 281,786 | 4.44M |
| 102 | REPL | Replimune Group, Inc. | 1.82B | -2.93% | 1,687,410 | - |
| 103 | MAZE | Maze Therapeutics, Inc. | 1.77B | 3.94% | 1,000,640 | 20.00M |
| 104 | STOK | Stoke Therapeutics, Inc. | 1.76B | 0.90% | 641,561 | 28.21M |
| 105 | RARE | Ultragenyx Pharmaceutical Inc. | 1.75B | -2.88% | 3,118,402 | 730.00M |
| 106 | AGIO | Agios Pharmaceuticals, Inc. | 1.72B | -3.10% | 590,436 | 140.84M |
| 107 | ZBIO | Zenas BioPharma, Inc. | 1.70B | -5.22% | 268,786 | 11.00M |
| 108 | RXRX | Recursion Pharmaceuticals, Inc. | 1.70B | -3.72% | 52,530,347 | 68.23M |
| 109 | KRSA | Korsana Biosciences, Inc. | 1.61B | 6.55% | 313,407 | - |
| 110 | ADRX | ADARx Pharmaceuticals, Inc. | 1.57B | 10.45% | 556,340 | 6.79M |
| 111 | BRVE | Braveheart Bio, Inc. | 1.57B | 3.99% | 1,107,919 | - |
| 112 | URGN | UroGen Pharma Ltd. | 1.56B | 6.51% | 1,903,405 | 250.25M |
| 113 | SRPT | Sarepta Therapeutics, Inc. | 1.52B | -2.48% | 2,069,126 | 1.96B |
| 114 | VIR | Vir Biotechnology, Inc. | 1.52B | -3.06% | 1,886,839 | 302.80M |
| 115 | DMRA | Damora Therapeutics, Inc. | 1.50B | 5.74% | 548,783 | - |
| 116 | KLRA | Kailera Therapeutics, Inc. | 1.50B | -1.78% | 473,966 | - |
| 117 | PGEN | Precigen, Inc. | 1.49B | -2.58% | 4,371,838 | 156.94M |
| 118 | NRIX | Nurix Therapeutics, Inc. | 1.49B | -3.55% | 2,257,973 | 701.94M |
| 119 | MESO | Mesoblast Limited | 1.48B | -3.95% | 262,556 | 120.25M |
| 120 | NBTX | Nanobiotix S.A. | 1.45B | 1.54% | 178,003 | 13.15M |
| 121 | QURE | uniQure N.V. | 1.42B | -0.34% | 1,200,525 | 20.17M |
| 122 | ABSI | Absci Corporation | 1.41B | -0.24% | 5,083,731 | 1.49M |
| 123 | ANAB | AnaptysBio, Inc. | 1.41B | 0.72% | 507,006 | 60.04M |
| 124 | SVRA | Savara Inc. | 1.40B | 10.38% | 12,302,277 | - |
| 125 | RAPP | Rapport Therapeutics, Inc. | 1.40B | 0.81% | 300,932 | 20.00M |
| 126 | WWB | Windward Bio Group AG | 1.39B | 6.05% | 166,311 | - |
| 127 | IMCR | Immunocore Holdings plc | 1.38B | -3.20% | 372,932 | 429.30M |
| 128 | TYRA | Tyra Biosciences, Inc. | 1.36B | 0.61% | 346,567 | - |
| 129 | NUVB | Nuvation Bio Inc. | 1.34B | 0.79% | 9,925,760 | 201.73M |
| 130 | GENB | Generate Biomedicines, Inc. | 1.34B | -0.10% | 835,699 | 21.07M |
| 131 | NTLA | Intellia Therapeutics, Inc. | 1.34B | -2.56% | 9,965,676 | 52.89M |
| 132 | INVA | Innoviva, Inc. | 1.31B | 0.05% | 839,635 | 438.32M |
| 133 | LBRX | LB Pharmaceuticals Inc | 1.30B | -0.05% | 405,425 | - |
| 134 | OCUL | Ocular Therapeutix, Inc. | 1.29B | -1.35% | 3,085,574 | 50.38M |
| 135 | AVLN | Avalyn Pharma Inc. | 1.28B | 3.65% | 437,390 | - |
| 136 | GHRS | GH Research PLC | 1.27B | 1.70% | 322,988 | - |
| 137 | NVAX | Novavax, Inc. | 1.27B | -3.02% | 4,354,735 | 411.65M |
| 138 | MNKD | MannKind Corporation | 1.27B | -2.95% | 4,077,092 | 413.37M |
| 139 | MLYS | Mineralys Therapeutics, Inc. | 1.25B | 2.76% | 1,171,698 | - |
| 140 | SLN | Silence Therapeutics plc | 1.23B | -0.05% | 174,455 | 456.00K |
| 141 | TSHA | Taysha Gene Therapies, Inc. | 1.23B | -5.51% | 2,175,154 | 5.49M |
| 142 | GPCR | Structure Therapeutics Inc. | 1.23B | -1.38% | 691,563 | - |
| 143 | KARD | Kardigan, Inc. | 1.17B | 1.62% | 977,804 | - |
| 144 | AAPG | Ascentage Pharma Group International | 1.15B | -4.40% | 1,487 | 94.61M |
| 145 | VOR | Vor Biopharma Inc. | 1.14B | 3.87% | 830,655 | - |
| 146 | NKTR | Nektar Therapeutics | 1.11B | -5.46% | 872,282 | 52.19M |
| 147 | INBX | Inhibrx Biosciences, Inc. | 1.10B | 7.63% | 420,893 | 2.00M |
| 148 | ANRO | Alto Neuroscience, Inc. | 1.06B | 2.32% | 573,019 | - |
| 149 | DRTS | Alpha Tau Medical Ltd. | 1.04B | -5.83% | 1,266,628 | - |
| 150 | OMER | Omeros Corporation | 1.04B | -3.71% | 1,286,695 | 74.36M |
| 151 | JBIO | Jade Biosciences, Inc. | 1.04B | -2.78% | 508,638 | - |
| 152 | SGP | SpyGlass Pharma, Inc. | 1.03B | 3.71% | 86,422 | - |
| 153 | SPTX | Seaport Therapeutics, Inc. | 980.68M | 0.05% | 321,041 | - |
| 154 | MLTX | MoonLake Immunotherapeutics | 938.73M | 2.22% | 1,449,332 | - |
| 155 | AKTS | Aktis Oncology, Inc. | 915.08M | 1.86% | 384,783 | 12.39M |
| 156 | CTY | City Therapeutics, Inc. | 913.04M | 10.28% | 245,887 | 14.34M |
| 157 | IMTX | Immatics N.V. | 905.99M | -2.46% | 986,465 | 49.33M |
| 158 | ODTX | Odyssey Therapeutics, Inc. | 879.24M | -3.37% | 419,243 | 99.00K |
| 159 | LTGO | Latigo Biotherapeutics, Inc. | 877.80M | -0.53% | 130,251 | - |
| 160 | PHAR | Pharming Group N.V. | 866.57M | -2.48% | 10,591 | 386.75M |
| 161 | VSTM | Verastem, Inc. | 864.46M | -0.15% | 3,723,391 | 100.30M |
| 162 | CRVS | Corvus Pharmaceuticals, Inc. | 844.37M | -1.77% | 705,567 | - |
| 163 | SNDX | Syndax Pharmaceuticals, Inc. | 821.96M | 6.66% | 3,306,280 | 289.68M |
| 164 | IVA | Inventiva S.A. | 820.80M | 1.77% | 3,061,295 | 2.81M |
| 165 | MTRI | Mentari Therapeutics, Inc. | 805.15M | -0.26% | 21,104 | - |
| 166 | ORIC | ORIC Pharmaceuticals, Inc. | 800.27M | 0.65% | 1,065,903 | - |
| 167 | MGTX | MeiraGTx Holdings plc | 795.53M | -2.16% | 964,916 | 401.91M |
| 168 | BBTX | Bambusa Therapeutics, Inc. | 792.15M | -2.20% | 151,498 | - |
| 169 | RIGL | Rigel Pharmaceuticals, Inc. | 775.61M | -3.15% | 341,416 | 288.21M |
| 170 | ARDX | Ardelyx, Inc. | 769.20M | -1.92% | 3,386,795 | 468.22M |
| 171 | GLUE | Monte Rosa Therapeutics, Inc. | 761.36M | -1.76% | 1,122,501 | 70.33M |
| 172 | OBX | Obsidian Therapeutics, Inc. | 750.54M | -0.49% | 361,889 | - |
| 173 | LXRX | Lexicon Pharmaceuticals, Inc. | 743.54M | -2.91% | 1,547,862 | 38.54M |
| 174 | OABI | OmniAb, Inc. | 733.68M | -0.98% | 1,748,320 | 40.21M |
| 175 | AURA | Aura Biosciences, Inc. | 726.44M | -2.24% | 495,305 | - |
| 176 | SLDB | Solid Biosciences Inc. | 718.77M | 1.42% | 1,739,431 | - |
| 177 | APMD | Apnimed, Inc. | 717.92M | -1.17% | 197,675 | 108.80M |
| 178 | ATTO | Attovia Therapeutics, Inc. | 712.20M | 0.32% | 159,315 | 1.44M |
| 179 | SGMT | Sagimet Biosciences Inc. | 686.56M | -4.85% | 1,026,681 | - |
| 180 | PRME | Prime Medicine, Inc. | 685.24M | 0.52% | 3,989,865 | 7.06M |
| 181 | NVCT | Nuvectis Pharma, Inc. | 682.28M | -2.22% | 158,978 | - |
| 182 | IAM | Iambic Therapeutics, Inc. | 675.94M | -3.39% | 298,089 | 18.25M |
| 183 | KURA | Kura Oncology, Inc. | 675.31M | 0.14% | 1,655,614 | 79.31M |
| 184 | ANNX | Annexon, Inc. | 650.51M | -3.12% | 3,188,726 | - |
| 185 | QUIT | Achieve Life Sciences, Inc. | 645.90M | -0.84% | 946,070 | - |
| 186 | JANX | Janux Therapeutics, Inc. | 629.58M | -0.19% | 651,228 | 23.29M |
| 187 | OLMA | Olema Oncology, Inc. | 626.38M | 1.27% | 1,848,183 | - |
| 188 | ABUS | Arbutus Biopharma Corporation | 623.90M | -0.97% | 2,435,771 | 181.49M |
| 189 | DBVT | DBV Technologies S.A. | 612.47M | -2.69% | 243,977 | 3.74M |
| 190 | BCAX | Bicara Therapeutics Inc. | 605.45M | -2.77% | 844,691 | - |
| 191 | FDMT | 4D Molecular Therapeutics, Inc. | 604.39M | 2.49% | 758,730 | 96.06M |
| 192 | DSGN | Design Therapeutics, Inc. | 596.82M | -1.58% | 266,861 | - |
| 193 | IMMX | Immix Biopharma, Inc. | 590.04M | -0.98% | 1,133,197 | - |
| 194 | CGEM | Cullinan Therapeutics, Inc. | 588.83M | 0.67% | 999,856 | - |
| 195 | GERN | Geron Corporation | 588.19M | -7.86% | 19,795,252 | 217.52M |
| 196 | SRZN | Surrozen, Inc. | 584.62M | -3.37% | 91,674 | 10.53M |
| 197 | ANL | Adlai Nortye Group Ltd. | 583.45M | 3.66% | 216,070 | 18.06M |
| 198 | AVBP | ArriVent BioPharma, Inc. | 582.40M | 3.30% | 906,598 | 5.00M |
| 199 | ENTX | Entera Bio Ltd. | 571.17M | 0.61% | 229,948 | 42.00K |
| 200 | ALMS | Alumis Inc. | 562.12M | -1.48% | 1,476,459 | 7.24M |
| 201 | ETRA | Electra Therapeutics, Inc. | 561.14M | 6.05% | 413,755 | - |
| 202 | ACRS | Aclaris Therapeutics, Inc. | 555.14M | 0.00% | 1,894,247 | 6.40M |
| 203 | CBIO | Crescent Biopharma, Inc. | 552.56M | 4.11% | 262,059 | 15.00M |
| 204 | OBIO | Orchestra BioMed Holdings, Inc. | 550.93M | -6.17% | 479,793 | 31.21M |
| 205 | CLYM | Climb Bio, Inc. | 545.09M | -0.22% | 586,596 | - |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 539.71M | -2.26% | 670,291 | 147.76M |
| 207 | WVE | Wave Life Sciences, Inc. | 536.46M | -1.81% | 1,923,967 | 70.92M |
| 208 | DNA | Ginkgo Bioworks Holdings, Inc. | 531.50M | -2.84% | 2,837,970 | 130.75M |
| 209 | SANA | Sana Biotechnology, Inc. | 521.36M | -5.95% | 4,016,866 | - |
| 210 | VALN | Valneva SE | 511.61M | 0.47% | 1,503 | 163.30M |
| 211 | HELP | Helus Pharma Inc. | 495.35M | -1.60% | 2,055,495 | - |
| 212 | GYRE | Gyre Therapeutics, Inc. | 494.72M | 4.15% | 268,927 | 110.06M |
| 213 | INDP | Indaptus Therapeutics, Inc. | 480.71M | -4.86% | 101,970 | - |
| 214 | MNPR | Monopar Therapeutics Inc. | 476.34M | -0.65% | 138,678 | - |
| 215 | FENC | Fennec Pharmaceuticals Inc. | 474.85M | 0.90% | 460,472 | 66.37M |
| 216 | RGNX | REGENXBIO Inc. | 474.76M | -1.10% | 808,285 | 153.91M |
| 217 | NGNE | Neurogene Inc. | 474.67M | -0.91% | 151,336 | 925.00K |
| 218 | STTK | Shattuck Labs, Inc. | 463.38M | 1.79% | 1,386,453 | 1.00M |
| 219 | ASMB | Assembly Biosciences, Inc. | 460.74M | 0.49% | 268,433 | 67.01M |
| 220 | OCS | Oculis Holding AG | 459.29M | 0.68% | 153,987 | 1.12M |
| 221 | BLSM | BlossomHill Therapeutics, Inc. | 458.02M | -1.23% | 215,242 | - |
| 222 | MDXG | MiMedx Group, Inc. | 453.83M | -2.20% | 2,019,670 | 303.73M |
| 223 | CTMX | CytomX Therapeutics, Inc. | 446.91M | 9.04% | 5,173,650 | 14.03M |
| 224 | OVID | Ovid Therapeutics Inc. | 441.63M | 3.54% | 1,766,294 | 1.45M |
| 225 | ARVN | Arvinas, Inc. | 441.37M | -0.44% | 843,628 | 275.30M |
| 226 | RZLT | Rezolute, Inc. | 440.59M | -1.18% | 2,373,642 | - |
| 227 | CAPR | Capricor Therapeutics, Inc. | 437.81M | -6.23% | 8,055,671 | 11.13M |
| 228 | IRLA | IRulya Therapeutics Inc. | 433.01M | -1.60% | 114,421 | - |
| 229 | DMAC | DiaMedica Therapeutics Inc. | 432.74M | -6.64% | 375,716 | - |
| 230 | TVGN | Tevogen Inc. | 432.68M | 2.61% | 7,176 | - |
| 231 | PRTA | Prothena Corporation plc | 431.34M | 0.60% | 566,979 | 52.74M |
| 232 | EPRX | Eupraxia Pharmaceuticals Inc. | 412.69M | -1.45% | 739,736 | - |
| 233 | TECX | Tectonic Therapeutic, Inc. | 411.32M | 0.00% | 87,172 | - |
| 234 | CRMD | CorMedix Inc. | 404.05M | 12.89% | 3,551,323 | 412.49M |
| 235 | PHAT | Phathom Pharmaceuticals, Inc. | 403.50M | -4.15% | 1,034,034 | 274.88M |
| 236 | CADL | Candel Therapeutics, Inc. | 402.43M | -3.57% | 1,194,885 | - |
| 237 | IRD | Opus Genetics, Inc. | 394.35M | 4.08% | 598,163 | 7.91M |
| 238 | AVTX | Avalo Therapeutics, Inc. | 390.31M | 0.75% | 710,330 | 59.00K |
| 239 | PBYI | Puma Biotechnology, Inc. | 368.09M | -1.39% | 469,418 | 231.83M |
| 240 | MPLT | MapLight Therapeutics, Inc. | 360.85M | -3.46% | 416,119 | - |
| 241 | ASPE | Aspen Neuroscience, Inc. | 360.28M | 3.16% | 289,292 | - |
| 242 | CTNM | Contineum Therapeutics, Inc. | 354.96M | -2.16% | 197,703 | - |
| 243 | ALEC | Alector, Inc. | 342.42M | -10.51% | 1,634,736 | 173.47M |
| 244 | LRMR | Larimar Therapeutics, Inc. | 338.53M | -0.16% | 1,117,823 | - |
| 245 | SPRY | ARS Pharmaceuticals, Inc. | 337.78M | -8.94% | 3,649,005 | 122.14M |
| 246 | PRLD | Prelude Therapeutics Incorporated | 336.12M | -1.36% | 200,815 | 21.57M |
| 247 | LYEL | Lyell Immunopharma, Inc. | 333.87M | -2.23% | 144,167 | 15.00K |
| 248 | RLMD | Relmada Therapeutics, Inc. | 331.82M | 8.93% | 1,708,620 | - |
| 249 | SLBT | SL Science Holding Limited | 331.44M | -11.93% | 44,332 | 3.27M |
| 250 | YDES | YD Bio Limited | 322.99M | -5.98% | 46,633 | 1.24M |
| 251 | PROK | ProKidney Corp. | 320.52M | 1.92% | 1,652,329 | 775.00K |
| 252 | CCCC | C4 Therapeutics, Inc. | 320.41M | -1.41% | 2,729,065 | 32.28M |
| 253 | INO | Inovio Pharmaceuticals, Inc. | 320.29M | 1.18% | 10,162,458 | 298.90K |
| 254 | AVIR | Atea Pharmaceuticals, Inc. | 315.60M | -1.50% | 291,342 | - |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 302.26M | -0.67% | 1,116,894 | 16.96M |
| 256 | EVMN | Evommune, Inc. | 299.37M | 5.23% | 474,979 | 10.00M |
| 257 | BNTC | Benitec Biopharma Inc. | 294.01M | -1.57% | 107,810 | - |
| 258 | GLSI | Greenwich LifeSciences, Inc. | 290.48M | -3.84% | 231,250 | - |
| 259 | GALT | Galectin Therapeutics Inc. | 283.46M | -5.70% | 220,444 | - |
| 260 | FULC | Fulcrum Therapeutics, Inc. | 283.38M | -0.27% | 681,950 | 80.00M |
| 261 | VCRE | Vicore Pharma Holding AB (publ) | 282.89M | 0.10% | 19,258 | 383.48K |
| 262 | AGEN | Agenus Inc. | 277.81M | -4.06% | 815,561 | 133.95M |
| 263 | AGMB | AgomAb Therapeutics NV | 276.77M | -3.44% | 320,729 | - |
| 264 | NAUT | Nautilus Biotechnology, Inc. | 276.40M | -10.70% | 3,389,447 | 424.00K |
| 265 | KYTX | Kyverna Therapeutics, Inc. | 276.28M | -2.46% | 824,797 | - |
| 266 | ALT | Altimmune, Inc. | 274.37M | 1.44% | 4,304,126 | 26.00K |
| 267 | PEPG | PepGen Inc. | 272.20M | 2.61% | 3,125,416 | - |
| 268 | TRXB | TRex Bio, Inc. | 265.45M | 3.51% | 190,325 | - |
| 269 | TTRX | Turn Therapeutics Inc. | 264.15M | -2.81% | 125,073 | - |
| 270 | EDIT | Editas Medicine, Inc. | 263.92M | -3.39% | 1,934,079 | 49.83M |
| 271 | DTIL | Precision BioSciences, Inc. | 263.76M | -2.68% | 269,139 | 45.04M |
| 272 | SABS | SAB Biotherapeutics, Inc. | 262.16M | -9.06% | 1,752,489 | 114.70K |
| 273 | IKT | Inhibikase Therapeutics, Inc. | 261.09M | -5.80% | 498,876 | 1.00 |
| 274 | AUTL | Autolus Therapeutics plc | 260.91M | -7.58% | 5,247,738 | 137.43M |
| 275 | PLX | Protalix BioTherapeutics, Inc. | 258.02M | 1.32% | 1,571,572 | 84.69M |
| 276 | EIKN | Eikon Therapeutics, Inc. | 257.93M | -7.93% | 436,830 | - |
| 277 | QTTB | Q32 Bio Inc. | 253.75M | -0.59% | 312,183 | 53.74M |
| 278 | CAMP | Camp4 Therapeutics Corporation | 251.02M | -2.44% | 207,463 | 5.32M |
| 279 | SCTX | Scribe Therapeutics Inc. | 250.35M | -5.91% | 505,068 | 14.83M |
| 280 | OCGN | Ocugen, Inc. | 248.64M | -0.87% | 9,348,017 | 4.78M |
| 281 | LXEO | Lexeo Therapeutics, Inc. | 244.22M | 0.00% | 1,281,420 | - |
| 282 | CUVL | Clinuvel Pharmaceuticals Limited | 243.74M | -2.99% | 8,408 | 65.05M |
| 283 | IPSC | Century Therapeutics, Inc. | 239.71M | -4.35% | 815,528 | 109.16M |
| 284 | RCKT | Rocket Pharmaceuticals, Inc. | 235.60M | 0.00% | 2,560,827 | - |
| 285 | ENTA | Enanta Pharmaceuticals, Inc. | 232.69M | -3.04% | 497,438 | 63.00M |
| 286 | ALLO | Allogene Therapeutics, Inc. | 231.06M | -4.17% | 7,406,555 | 4.64M |
| 287 | FTH | Faeth Therapeutics, Inc. | 224.58M | -0.34% | 470,824 | - |
| 288 | KROS | Keros Therapeutics, Inc. | 223.52M | -5.08% | 367,045 | 40.76M |
| 289 | IMRX | Immuneering Corporation | 223.43M | -1.43% | 654,035 | - |
| 290 | VNDA | Vanda Pharmaceuticals Inc. | 221.92M | -2.13% | 639,166 | 229.28M |
| 291 | ARCT | Arcturus Therapeutics Holdings Inc. | 219.05M | -5.47% | 462,744 | 30.51M |
| 292 | CABA | Cabaletta Bio, Inc. | 217.88M | -4.27% | 3,271,769 | - |
| 293 | BCYC | Bicycle Therapeutics plc | 213.79M | -1.93% | 466,799 | 83.53M |
| 294 | ACIU | AC Immune SA | 211.78M | 1.43% | 605,415 | 23.75M |
| 295 | LCTX | Lineage Cell Therapeutics, Inc. | 209.23M | -2.21% | 1,311,724 | 10.84M |
| 296 | NGEN | NervGen Pharma Corp. | 206.44M | 1.05% | 653,470 | - |
| 297 | VTVT | vTv Therapeutics Inc. | 203.57M | 0.80% | 17,636 | 36.84M |
| 298 | PYXS | Pyxis Oncology, Inc. | 200.94M | 19.15% | 1,804,987 | 11.04M |
| 299 | DRUG | Bright Minds Biosciences Inc. | 199.74M | -0.29% | 110,364 | - |
| 300 | ANTX | AN2 Therapeutics, Inc. | 198.07M | 5.45% | 785,781 | - |
| 301 | ACOG | Alpha Cognition Inc. | 195.07M | 2.91% | 108,154 | 20.20M |
| 302 | MDWD | MediWound Ltd. | 193.49M | -0.51% | 171,647 | 10.01M |
| 303 | VOGX | Vogenx, Inc. | 190.22M | 3.77% | 144,355 | - |
| 304 | ARTV | Artiva Biotherapeutics, Inc. | 189.33M | 1.59% | 773,210 | 251.00K |
| 305 | WHWK | Whitehawk Therapeutics, Inc. | 184.11M | -0.32% | 395,726 | 7.15M |
| 306 | RNAC | Cartesian Therapeutics, Inc. | 179.66M | -6.51% | 384,654 | 1.03M |
| 307 | CGEN | Compugen Ltd. | 178.08M | -4.08% | 262,526 | 75.93M |
| 308 | SLGL | Sol-Gel Technologies Ltd. | 177.19M | 1.35% | 45,028 | 1.44M |
| 309 | TRDA | Entrada Therapeutics, Inc. | 169.39M | -7.75% | 341,089 | 3.98M |
| 310 | KRRO | Korro Bio, Inc. | 167.32M | -2.01% | 107,442 | 1.29M |
| 311 | PALI | Palisade Bio, Inc. | 165.90M | -1.77% | 2,745,323 | 500.00K |
| 312 | IFRX | InflaRx N.V. | 160.63M | -1.80% | 664,630 | -38.53K |
| 313 | ELDN | Eledon Pharmaceuticals, Inc. | 160.63M | -6.40% | 854,192 | - |
| 314 | ORMP | Oramed Pharmaceuticals Inc. | 160.46M | -5.14% | 272,916 | 2.00M |
| 315 | HUMA | Humacyte, Inc. | 150.71M | 8.50% | 3,747,640 | 2.40M |
| 316 | RNA | Atrium Therapeutics, Inc. | 150.57M | 5.12% | 225,886 | 38.82M |
| 317 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 149.27M | 3.05% | 366,735 | - |
| 318 | PRQR | ProQR Therapeutics N.V. | 148.40M | -4.55% | 806,867 | 23.46M |
| 319 | TARA | Protara Therapeutics, Inc. | 147.77M | 2.56% | 1,243,730 | - |
| 320 | VRXA | Veraxa Biotech AG | 145.65M | 0.00% | 115,905 | 29.54K |
| 321 | STRO | Sutro Biopharma, Inc. | 144.76M | 2.59% | 243,091 | 45.11M |
| 322 | ABEO | Abeona Therapeutics Inc. | 140.01M | -10.26% | 1,910,972 | 39.01M |
| 323 | PYPD | PolyPid Ltd. | 138.37M | -0.15% | 454,272 | - |
| 324 | ADAG | Adagene Inc. | 134.96M | 10.44% | 1,178,313 | 9.29M |
| 325 | SION | Sionna Therapeutics, Inc. | 134.35M | 0.00% | 648,411 | - |
| 326 | ZNTL | Zentalis Pharmaceuticals, Inc. | 133.64M | 0.00% | 1,448,337 | 26.87M |
| 327 | YARW | Yarrow Bioscience, Inc. | 132.40M | -0.84% | 159,739 | - |
| 328 | ALXO | ALX Oncology Holdings Inc. | 131.86M | 5.14% | 2,945,362 | - |
| 329 | IVVD | Invivyd, Inc. | 131.82M | -5.23% | 4,648,703 | 60.69M |
| 330 | MENS | Jyong Biotech Ltd. | 129.91M | -5.91% | 80,032 | - |
| 331 | MGNX | MacroGenics, Inc. | 126.54M | 0.51% | 932,908 | 140.81M |
| 332 | MSLE | Satellos Bioscience Inc. | 126.01M | -2.36% | 75,547 | - |
| 333 | FATE | Fate Therapeutics, Inc. | 122.78M | -3.81% | 1,734,127 | 4.75M |
| 334 | CMPX | Compass Therapeutics, Inc. | 122.19M | 11.05% | 1,679,455 | 850.00K |
| 335 | ENGN | enGene Therapeutics Inc. | 117.95M | -4.86% | 1,008,085 | - |
| 336 | SPRB | Spruce Biosciences, Inc. | 116.37M | -0.86% | 48,087 | 697.00K |
| 337 | CDXS | Codexis, Inc. | 115.08M | -8.70% | 913,303 | 88.34M |
| 338 | OKUR | OnKure Therapeutics, Inc. | 111.79M | -2.13% | 135,995 | - |
| 339 | ARMP | Armata Pharmaceuticals, Inc. | 110.83M | -5.99% | 73,680 | 7.56M |
| 340 | NRXP | NRx Pharmaceuticals, Inc. | 110.32M | -8.93% | 1,397,336 | 4.31M |
| 341 | UPB | Upstream Bio, Inc. | 109.62M | -3.85% | 856,120 | 2.87M |
| 342 | RTSN | Retension Pharmaceuticals, Inc. | 108.39M | -6.34% | 54,566 | - |
| 343 | FHTX | Foghorn Therapeutics Inc. | 106.73M | -0.56% | 484,010 | 112.13M |
| 344 | NERV | Minerva Neurosciences, Inc. | 105.65M | -2.75% | 163,539 | - |
| 345 | LENZ | LENZ Therapeutics, Inc. | 104.94M | 4.05% | 642,440 | 12.36M |
| 346 | UNCY | Unicycive Therapeutics, Inc. | 103.02M | -1.12% | 886,066 | - |
| 347 | GNLX | Genelux Corporation | 102.17M | 1.79% | 210,182 | 8.00K |
| 348 | NBP | NovaBridge Biosciences | 102.06M | -2.58% | 213,654 | - |
| 349 | ICCC | ImmuCell Corporation | 101.45M | -0.71% | 12,688 | 33.21M |
| 350 | IMUX | Immunic, Inc. | 100.83M | -1.73% | 390,615 | - |
| 351 | CNTN | Canton Strategic Holdings, Inc. | 100.42M | -7.87% | 1,086,644 | 4.47M |
| 352 | VYGR | Voyager Therapeutics, Inc. | 100.19M | -3.59% | 709,291 | 25.11M |
| 353 | PDSB | PDS Biotechnology Corporation | 99.06M | 2.96% | 2,348,718 | - |
| 354 | PMVP | PMV Pharmaceuticals, Inc. | 98.95M | 7.38% | 1,196,295 | - |
| 355 | VANI | Vivani Medical, Inc. | 98.32M | 3.81% | 210,783 | - |
| 356 | OTLK | Outlook Therapeutics, Inc. | 97.62M | -1.69% | 6,830,989 | -1.16M |
| 357 | NTHI | NeOnc Technologies Holdings, Inc. | 96.64M | -16.35% | 387,986 | 39.99K |
| 358 | MOLN | Molecular Partners AG | 94.31M | -3.94% | 77 | 856.30K |
| 359 | CBUS | Cibus, Inc. | 94.01M | -10.22% | 189,710 | 4.53M |
| 360 | IPHA | Innate Pharma S.A. | 93.07M | -8.75% | 64,652 | 11.21M |
| 361 | ZURA | Zura Bio Limited | 91.74M | -1.32% | 2,083,597 | - |
| 362 | ANIX | Anixa Biosciences, Inc. | 90.39M | -4.06% | 227,126 | - |
| 363 | EQ | Equillium, Inc. | 87.77M | 1.82% | 597,927 | 4.39M |
| 364 | HURA | TuHURA Biosciences, Inc. | 86.67M | -0.73% | 202,489 | - |
| 365 | TLSA | Tiziana Life Sciences Ltd | 86.50M | -16.43% | 339,106 | - |
| 366 | RLYB | Rallybio Corporation | 83.56M | 1.70% | 40,616 | 434.00K |
| 367 | RANI | Rani Therapeutics Holdings, Inc. | 80.97M | -10.42% | 535,306 | 6.58M |
| 368 | NKTX | Nkarta, Inc. | 80.31M | -2.61% | 663,712 | - |
| 369 | BDTX | Black Diamond Therapeutics, Inc. | 79.88M | -2.80% | 460,235 | 70.00M |
| 370 | SEER | Seer, Inc. | 77.30M | -3.82% | 245,007 | 14.08M |
| 371 | CING | Cingulate Inc. | 76.49M | 2.94% | 607,282 | - |
| 372 | PLYX | Polaryx Therapeutics, Inc. | 75.27M | -6.21% | 13,262 | - |
| 373 | CLLS | Cellectis S.A. | 74.69M | -4.49% | 65,445 | 32.10M |
| 374 | TENX | Tenax Therapeutics, Inc. | 74.52M | -2.80% | 751,280 | - |
| 375 | KZIA | Kazia Therapeutics Limited | 73.59M | -2.19% | 279,539 | 1.32M |
| 376 | MAIA | MAIA Biotechnology, Inc. | 70.40M | -12.31% | 989,288 | - |
| 377 | COYA | Coya Therapeutics, Inc. | 69.90M | -3.56% | 71,123 | 4.69M |
| 378 | CRDF | Cardiff Oncology, Inc. | 69.44M | 6.39% | 726,384 | 559.00K |
| 379 | GOSS | Gossamer Bio, Inc. | 68.69M | -1.75% | 146,313 | 78.42M |
| 380 | TNYA | Tenaya Therapeutics, Inc. | 68.04M | -2.74% | 4,033,788 | 3.03M |
| 381 | NMRA | Neumora Therapeutics, Inc. | 65.48M | -5.40% | 453,951 | - |
| 382 | ATRA | Atara Biotherapeutics, Inc. | 64.59M | -6.35% | 9,884 | 3.97M |
| 383 | CNXU | Conexeu Sciences Inc. | 64.13M | -11.68% | 576,681 | - |
| 384 | NRXS | NeurAxis, Inc. | 63.87M | -7.60% | 143,673 | 6.53M |
| 385 | MNOV | MediciNova, Inc. | 62.51M | -4.51% | 93,407 | 935.72K |
| 386 | AVXL | Anavex Life Sciences Corp. | 61.88M | -7.21% | 1,283,956 | - |
| 387 | CSBR | Champions Oncology, Inc. | 61.24M | -0.90% | 4,870 | 60.66M |
| 388 | OKYO | OKYO Pharma Limited | 60.88M | 5.45% | 752,356 | - |
| 389 | NTRB | Nutriband Inc. | 60.78M | 3.74% | 14,276 | 1.62M |
| 390 | ACRV | Acrivon Therapeutics, Inc. | 59.99M | -10.26% | 375,006 | - |
| 391 | CHRS | Coherus Oncology, Inc. | 59.82M | -5.56% | 3,982,079 | 53.64M |
| 392 | FBIO | Fortress Biotech, Inc. | 59.03M | -6.35% | 210,793 | 69.99M |
| 393 | NORD | Nordicus Partners Corporation | 57.15M | 2.81% | 4,108 | - |
| 394 | CGTX | Cognition Therapeutics, Inc. | 57.12M | 0.10% | 332,718 | - |
| 395 | IBIO | iBio, Inc. | 56.44M | -5.55% | 427,019 | 1.08M |
| 396 | MIST | Milestone Pharmaceuticals Inc. | 56.27M | -13.27% | 1,284,915 | 5.31M |
| 397 | BOLD | Boundless Bio, Inc. | 56.19M | -0.83% | 131,395 | - |
| 398 | AZR | Azora Therapeutics, Inc. | 55.29M | 1.84% | 79,692 | - |
| 399 | XLO | Xilio Therapeutics, Inc. | 53.05M | -1.57% | 3,456 | 55.01M |
| 400 | XBIT | XBiotech Inc. | 51.22M | -2.89% | 47,981 | - |
| 401 | RNXT | RenovoRx, Inc. | 50.66M | -6.25% | 421,137 | 2.78M |
| 402 | CLNN | Clene Inc. | 50.40M | 2.34% | 122,230 | 238.00K |
| 403 | HRTX | Heron Therapeutics, Inc. | 50.25M | -3.26% | 3,608,724 | 148.22M |
| 404 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 50.18M | -11.29% | 660,374 | - |
| 405 | ONCY | Oncolytics Biotech Inc. | 49.81M | -11.29% | 1,697,689 | - |
| 406 | VRCA | Verrica Pharmaceuticals Inc. | 49.56M | 1.05% | 77,983 | 22.89M |
| 407 | TNXP | Tonix Pharmaceuticals Holding Corp. | 49.55M | -9.57% | 890,339 | 43.05M |
| 408 | SPRO | Spero Therapeutics, Inc. | 48.12M | -5.46% | 560,797 | 41.56M |
| 409 | HOWL | Werewolf Therapeutics, Inc. | 47.90M | -4.30% | 561,216 | 21.00M |
| 410 | GANX | Gain Therapeutics, Inc. | 46.75M | -5.41% | 556,509 | - |
| 411 | ANVS | Annovis Bio, Inc. | 46.42M | -11.01% | 1,459,006 | - |
| 412 | IMA | ImageneBio, Inc. | 45.18M | 4.46% | 27,538 | 800.00K |
| 413 | INKT | MiNK Therapeutics, Inc. | 43.94M | -2.60% | 14,856 | 200.00K |
| 414 | MREO | Mereo BioPharma Group plc | 43.92M | -4.94% | 882,127 | 800.00K |
| 415 | ALDX | Aldeyra Therapeutics, Inc. | 43.56M | 7.54% | 861,140 | - |
| 416 | ELOX | Eloxx Pharmaceuticals, Inc. | 42.99M | 2.31% | 15,863 | - |
| 417 | BMEA | Biomea Fusion, Inc. | 42.76M | 11.02% | 951,789 | - |
| 418 | ELTX | Elicio Therapeutics, Inc. | 42.46M | -5.66% | 131,568 | - |
| 419 | DWTX | Dogwood Therapeutics, Inc. | 40.52M | -1.85% | 126,365 | 100.00K |
| 420 | CNTB | Connect Biopharma Holdings Limited | 40.51M | -5.56% | 486,477 | 3.67M |
| 421 | ALPS | Alps Group Inc | 39.60M | 0.00% | 71,695 | 3.74M |
| 422 | PLRX | Pliant Therapeutics, Inc. | 38.39M | -6.20% | 746,799 | - |
| 423 | OSTX | OS Therapies Incorporated | 37.91M | -10.82% | 480,844 | - |
| 424 | TIL | Instil Bio, Inc. | 37.64M | 2.21% | 61,882 | - |
| 425 | HYFT | MindWalk Holdings Corp. | 37.61M | -11.30% | 416,425 | 11.57M |
| 426 | APLM | Apollomics, Inc. | 36.97M | 1.46% | 961 | 445.00K |
| 427 | GRCE | Grace Therapeutics, Inc. | 36.39M | 0.00% | 99,759 | - |
| 428 | HYPD | Hyperion DeFi, Inc. | 36.14M | -1.47% | 87,242 | 1.91M |
| 429 | VERU | Veru Inc. | 35.98M | -8.66% | 77,037 | 16.89M |
| 430 | ATNM | Actinium Pharmaceuticals, Inc. | 33.64M | -0.93% | 166,510 | 35.00M |
| 431 | CRBU | Caribou Biosciences, Inc. | 33.55M | -4.78% | 1,813,987 | 9.44M |
| 432 | CUE | Cue Biopharma, Inc. | 32.69M | -5.46% | 2,088,520 | 35.64M |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 32.40M | 4.59% | 240,773 | - |
| 434 | KLRS | Kalaris Therapeutics, Inc. | 32.14M | -1.46% | 24,100 | - |
| 435 | RNTX | Rein Therapeutics Inc. | 31.72M | 3.49% | 1,672,310 | - |
| 436 | EXOZ | eXoZymes, Inc. | 31.37M | -1.46% | 21,535 | -700.00 |
| 437 | NXTC | NextCure, Inc. | 31.05M | -1.60% | 29,403 | - |
| 438 | SER | Serina Therapeutics, Inc. | 30.48M | -11.11% | 68,102 | 125.00K |
| 439 | EYPT | EyePoint, Inc. | 30.06M | -2.87% | 3,447,525 | 2.58M |
| 440 | NNVC | NanoViricides, Inc. | 29.86M | -1.68% | 163,074 | - |
| 441 | ATHE | Alterity Therapeutics Limited | 29.82M | -2.65% | 36,185 | 2.50M |
| 442 | EDSA | Edesa Biotech, Inc. | 29.39M | 5.58% | 215,642 | - |
| 443 | PMN | ProMIS Neurosciences, Inc. | 28.79M | 2.56% | 172,340 | - |
| 444 | BCTX | BriaCell Therapeutics Corp. | 28.36M | -3.66% | 63,866 | - |
| 445 | FLNA | Filana Therapeutics, Inc. | 28.15M | 2.75% | 781,742 | - |
| 446 | INMB | INmune Bio Inc. | 27.68M | -13.19% | 418,858 | 50.00K |
| 447 | PTHS | Pelthos Therapeutics Inc. | 27.48M | -1.55% | 64,641 | 51.29M |
| 448 | ACET | Adicet Bio, Inc. | 26.48M | -1.60% | 281,228 | - |
| 449 | CVM | CEL-SCI Corporation | 25.86M | 6.52% | 267,066 | - |
| 450 | IMMP | Immutep Limited | 25.58M | 5.23% | 81,493 | 13.79M |
| 451 | LITS | Lite Strategy, Inc. | 24.99M | 3.61% | 134,256 | - |
| 452 | PLRZ | Polyrizon Ltd. | 24.69M | -7.84% | 2,229 | - |
| 453 | GRDX | GridAI Technologies Corp. | 24.43M | 2.68% | 81,344 | - |
| 454 | MGX | Metagenomi Therapeutics, Inc. | 23.21M | -2.85% | 124,464 | 7.09M |
| 455 | LONA | LeonaBio, Inc. | 23.18M | -7.17% | 84,852 | - |
| 456 | ABVC | ABVC BioPharma, Inc. | 23.10M | -3.34% | 57,508 | 797.92K |
| 457 | RNAZ | TransCode Therapeutics, Inc. | 22.50M | -3.35% | 17,103 | - |
| 458 | MRKR | Marker Therapeutics, Inc. | 22.01M | 54.71% | 36,085,341 | 2.31M |
| 459 | AARD | Aardvark Therapeutics, Inc. | 21.88M | 9.89% | 486,478 | - |
| 460 | IGC | IGC Pharma, Inc. | 21.47M | -5.45% | 533,652 | 1.11M |
| 461 | CRVO | CervoMed Inc. | 20.12M | -8.28% | 284,751 | 8.73K |
| 462 | EVAX | Evaxion A/S | 18.72M | -20.08% | 149,506 | 7.49M |
| 463 | COCP | Cocrystal Pharma, Inc. | 18.68M | -0.72% | 10,895 | 435.00K |
| 464 | BYSI | BeyondSpring Inc. | 17.97M | -3.53% | 33,285 | 1.88M |
| 465 | ATOS | Atossa Therapeutics, Inc. | 17.46M | -3.31% | 26,153 | - |
| 466 | LPCN | Lipocine Inc. | 16.61M | -1.32% | 249,939 | 3.74M |
| 467 | QNRX | Quoin Pharmaceuticals, Ltd. | 16.14M | -5.64% | 11,049 | - |
| 468 | KTTA | Pasithea Therapeutics Corp. | 16.07M | -5.85% | 344,911 | - |
| 469 | NCEL | NewcelX Ltd. | 15.54M | 1.51% | 4,808 | - |
| 470 | CNTX | Context Therapeutics Inc. | 15.49M | 1.32% | 981,729 | - |
| 471 | AKTX | Akari Therapeutics, Plc | 15.33M | 0.90% | 9,850 | - |
| 472 | CELU | Celularity Inc. | 15.18M | -3.15% | 109,343 | 18.67M |
| 473 | ESLA | Estrella Immunopharma, Inc. | 14.81M | 2.25% | 223,923 | - |
| 474 | ABOS | Acumen Pharmaceuticals, Inc. | 13.98M | -0.57% | 2,161,324 | - |
| 475 | PLUR | Pluri Inc. | 13.94M | 5.98% | 11,862 | 1.46M |
| 476 | ALLR | Allarity Therapeutics, Inc. | 13.76M | -0.80% | 139,593 | 350.00K |
| 477 | CTXR | Citius Pharmaceuticals, Inc. | 13.65M | -2.64% | 141,328 | 7.11M |
| 478 | MCRB | Seres Therapeutics, Inc. | 13.56M | -7.64% | 54,664 | 2.13M |
| 479 | BOLT | Bolt Biotherapeutics, Inc. | 13.19M | -0.78% | 35,612 | 4.70M |
| 480 | BSEM | BioStem Technologies, Inc. | 13.15M | -13.53% | 323,989 | 31.75M |
| 481 | GUTS | Fractyl Health, Inc. | 12.67M | -11.55% | 224,458 | 3.00K |
| 482 | TVRD | Tvardi Therapeutics, Inc. | 12.62M | -9.03% | 77,908 | - |
| 483 | NEUP | Neuphoria Therapeutics Inc. | 12.55M | 1.75% | 17,854 | 1.17M |
| 484 | QNTM | Quantum BioPharma Ltd. | 12.44M | -6.58% | 78,931 | - |
| 485 | JSPR | Jasper Therapeutics, Inc. | 11.92M | -6.68% | 10,927 | - |
| 486 | ACTU | Actuate Therapeutics, Inc. | 11.76M | -12.95% | 3,015,359 | - |
| 487 | BCDA | BioCardia, Inc. | 11.70M | 0.08% | 157,429 | 3.00K |
| 488 | PASG | Passage Bio, Inc. | 11.62M | -12.70% | 3,707 | - |
| 489 | DYAI | Dyadic International, Inc. | 11.33M | -2.91% | 139,992 | 3.09M |
| 490 | PBM | Psyence Biomedical Ltd. | 10.91M | 13.94% | 83,350 | - |
| 491 | PPBT | Purple Biotech Ltd | 10.49M | -10.53% | 16,160 | - |
| 492 | HIND | Vyome Holdings, Inc. | 10.18M | -3.97% | 19,269 | 153.10K |
| 493 | BIVI | BioVie Inc. | 9.75M | -3.50% | 159,298 | - |
| 494 | TCRX | TScan Therapeutics, Inc. | 9.67M | -3.84% | 507,198 | 5.19M |
| 495 | LEXX | Lexaria Bioscience Corp. | 9.46M | 4.91% | 27,479 | 194.00K |
| 496 | ATYR | aTyr Pharma, Inc. | 9.41M | -9.56% | 80,608 | 190.00K |
| 497 | PTN | Palatin Technologies, Inc. | 9.38M | -4.27% | 13,864 | 4.70M |
| 498 | GDTC | CytoMed Therapeutics Limited | 9.23M | -6.87% | - | 609.73K |
| 499 | DARE | Daré Bioscience, Inc. | 8.89M | 0.44% | 181,071 | 1.41M |
| 500 | CLRB | Cellectar Biosciences, Inc. | 8.86M | -0.26% | 88,075 | - |